Attached files

file filename
10-K - ALNYLAM PHARMACEUTICALS, INC. - ALNYLAM PHARMACEUTICALS, INC.b78674e10vk.htm
EX-21.1 - EX-21.1 SUBSIDIARIES OF THE REGISTRANT - ALNYLAM PHARMACEUTICALS, INC.b78674exv21w1.htm
EX-23.2 - EX-23.2 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS OF REGULUS THERAPEUTICS INC. - ALNYLAM PHARMACEUTICALS, INC.b78674exv23w2.htm
EX-31.2 - EX-31.2 SECTION 302 CERTIFICATION OF THE VICE PRESIDENT OF FINANCE AND TREASURER - ALNYLAM PHARMACEUTICALS, INC.b78674exv31w2.htm
EX-99.1 - EX-99.1 REGULUS THERAPEUTICS INC.'S FINANCIAL STATEMENTS - ALNYLAM PHARMACEUTICALS, INC.b78674exv99w1.htm
EX-32.2 - EX-32.2 SECTION 906 CERTIFICATION OF THE VICE PRESIDENT OF FINANCE AND TREASURER - ALNYLAM PHARMACEUTICALS, INC.b78674exv32w2.htm
EX-31.1 - EX-31.1 SECTION 302 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - ALNYLAM PHARMACEUTICALS, INC.b78674exv31w1.htm
EX-32.1 - EX-32.1 SECTION 906 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER - ALNYLAM PHARMACEUTICALS, INC.b78674exv32w1.htm
EX-10.16 - EX-10.16 2010 ANNUAL INCENTIVE PROGRAM - ALNYLAM PHARMACEUTICALS, INC.b78674exv10w16.htm
EX-10.39 - EX-10.39 COLLABORATION AGREEMENT ENTERED INTO AS OF OCTOBER 29, 2009 - ALNYLAM PHARMACEUTICALS, INC.b78674exv10w39.htm
EX-10.40 - EX-10.40 FIRST AMENDMENT TO LICENSE AND COLLABORATION AGREEMENT ENTERED INTO AS OF NOVEMBER 2, 2009 - ALNYLAM PHARMACEUTICALS, INC.b78674exv10w40.htm
EX-10.9 - EX-10.9 FORMS OF INCENTIVE STOCK OPTION AGREEMENT AND NONSTATUTORY STOCK OPTION AGREEMENT - ALNYLAM PHARMACEUTICALS, INC.b78674exv10w9.htm
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-138586, 333-131233, 333-129905 and 333-140076) and Registration Statements on Form S-8 (Nos. 333-127450, 333-116151 333-148114 and 333-157633) of Alnylam Pharmaceuticals, Inc. of our report dated February 26, 2010 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
February 26, 2010